To predict the occurrence of pCR subsequent to neoadjuvant chemoradiotherapy for rectal cancer, we incorporated factors exhibiting statistically significant differences in the univariate logistic regression analysis, namely, histology, CEA levels, clinical N stage, CRM status, and NLR, into the development of a nomogram (Figure 2A). The gene discussed is CEACAM5; the disease is rectal cancer.